Menu

Blog

Archive for the ‘health’ category: Page 202

Apr 14, 2020

At Least 70 Coronavirus Vaccines Are Already in Development, WHO Report Shows

Posted by in categories: biotech/medical, health

At least 70 potential coronavirus vaccines are currently in development, with 3 already in clinical trials, according to the World Health Organisation.

WHO published an updated list of vaccine efforts on April 11, showing a vast array of companies pursuing shots that could halt the coronavirus. Bloomberg News reported on the document earlier.

As the virus continues to spread, infecting more than 1.9 million people and killing more than 110,000 worldwide, researchers have been racing to develop vaccines.

Apr 13, 2020

The role of global cooperation in space after COVID-19

Posted by in categories: biotech/medical, business, education, food, government, health, neuroscience

The coronavirus pandemic has resulted in the deaths of tens of thousands of people across the globe. It is also causing huge damage to the global economy. According to the predictions of the International Monetary Fund (IMF), 2020 could be the worst year since the Great Depression in the 1930s, with more than 170 countries likely to experience negative per capita income growth due to the pandemic. Countries are taking different measures to mitigate that economic impact, depending on the situations in their countries. However, the process of overcoming economic crisis is going to be extremely difficult. Few businesses would find it hard even to sustain and there is going to be a significant upsurge in unemployment rates.

Like much of the rest of the world, India is under lockdown. It is bit premature to predict the exact impact of coronavirus crisis on the Indian economy since the situation is still evolving. However, it is clear at this stage that the country will be facing major economic downturn and levels of unemployment will steeply rise. The government has already offered an economic package of 1.7 trillion rupees ($22.3 billion) in the last month for providing food security and money to the poor. It is expected that the government would shortly announce the next economic stimulus package.

All this would require the government of India to undertake a ruthless review of existing patterns of expenditure. The government budgeting caters to the requirements of various segments of the society, including agriculture, health, education, and railways. The budget has two other important areas of attention: defense and science & technology.

Apr 13, 2020

Whooping cough resurgence due to vaccinated people not knowing they’re infectious?

Posted by in categories: biotech/medical, health

Whooping cough has made an astonishing comeback, with 2012 seeing nearly 50,000 infections in the U.S. (the most since 1955), and a death rate in infants three times that of the rest of the population. The dramatic resurgence has puzzled public health officials, who have pointed to the waning effectiveness of the current vaccine and growing anti-vaccine sentiment as the most likely culprits.

But that might not be the whole story, suggests a new study published in BMC Medicine by Santa Fe Institute Omidyar Fellows Ben Althouse and Sam Scarpino. Their research points to a different, but related, source of the outbreak — vaccinated people who are infectious but who do not display the symptoms of whooping cough, suggesting that the number of people transmitting without symptoms may be many times greater than those transmitting with symptoms.

In the 1950s, highly successful vaccines based on inactivated pertussis cells (the bacteria that causes whooping cough) drove infection rates in the U.S. below one case per 100,000 people. But adverse side effects of those vaccines led to the development and introduction in the 1990s of acellular pertussis vaccines, which use just a handful of the bacteria’s proteins and bypass most of the side effects. (Currently given to children as part of the Tdap vaccine.)

Apr 13, 2020

COVID-19 Patients Given Unproven Drug In Texas Nursing Home In ‘Disconcerting’ Move

Posted by in categories: biotech/medical, health

Okay now I agree that Hyroxychloroquine works. Ventilators have a mortality rate of 80% yet people keep trashing this drug, while people like that French doctor say it works.

Doctors at nursing home: “It’s actually going well. People are getting better,” Armstrong told NPR, adding that after just a handful of days, some of the 39 patients on the medication are showing signs of improvement.”

“Paid Professionals:

Continue reading “COVID-19 Patients Given Unproven Drug In Texas Nursing Home In ‘Disconcerting’ Move” »

Apr 13, 2020

How the military secured a coronavirus drug that has yet to win FDA approval

Posted by in categories: biotech/medical, government, health, military

Among the drugs being investigated is remdesivir, an experimental antiviral made by the US drug company Gilead Sciences. It has been characterized as one of the most promising by health authorities, including WHO officials —though that optimism is inspired only by anecdotal information. US data on remdesivir’s performance in controlled clinical trials is expected next month, and data from late-stage trials conducted in China will be released by the end of April.

The US military, however, has already secured access to remdesivir for its service members.

On March 10, the Pentagon announced a deal with Gilead Sciences in which the pharmaceutical company would supply the military with the intravenous drug at no cost. “Together with our government and industry partners, we are progressing at almost revolutionary rates to deliver effective treatment and prevention products that will protect the citizens of the world and preserve the readiness and lethality of our service members,” Army Brig. Gen. Michael Talley, commanding general of the US Army Medical Research and Development Command (USAMRDC) and Fort Detrick, Maryland, said in a media statement at the time.

Apr 12, 2020

Why Some Doctors Are Now Moving Away From Ventilator Treatments for Coronavirus Patients

Posted by in categories: biotech/medical, health

#Repost “Some doctors are experimenting with adding nitric oxide to the mix, to help improve blood flow and oxygen to the least damaged parts of the lungs.”

Ironically enough nitric oxide improves blood oxygen flow, and also clears blood clots. Some patients who survive COVID19 have clots in the blood vessels in their lungs. We just have to wait and see.


(NEW YORK) — As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can. The reason: Some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.

Continue reading “Why Some Doctors Are Now Moving Away From Ventilator Treatments for Coronavirus Patients” »

Apr 12, 2020

5G dangers: mmWave microwaves and other health claims debunked

Posted by in categories: health, internet

Health hysteria has plagued the communications industry for decades despite the lack of evidence. 5G is no different.

Apr 11, 2020

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Posted by in categories: biotech/medical, health

A novel coronavirus (COVID-19 virus) outbreak has caused a global pandemic resulting in tens of thousands of infections and thousands of deaths worldwide. The RNA-dependent RNA polymerase (RdRp, also named nsp12) is the central component of coronaviral replication/transcription machinery and appears to be a primary target for the antiviral drug, remdesivir. We report the cryo-EM structure of COVID-19 virus full-length nsp12 in complex with cofactors nsp7 and nsp8 at 2.9-Å resolution. In addition to the conserved architecture of the polymerase core of the viral polymerase family, nsp12 possesses a newly identified β-hairpin domain at its N terminus. A comparative analysis model shows how remdesivir binds to this polymerase. The structure provides a basis for the design of new antiviral therapeutics targeting viral RdRp.

Corona Virus Disease 2019 (COVID-19) caused by a novel coronavirus emerged in December 2019 (13) and has since become a global pandemic. COVID-19 virus is reported to be a new member of the betacoronavirus genus and is closely related to severe acute respiratory syndrome coronavirus (SARS-CoV) and to several bat coronaviruses (4). Compared to SARS-CoV and MERS-CoV, COVID-19 virus exhibits faster human-to-human transmission, thus leading to the WHO declaration of a world-wide public health emergency (1, 2).

CoVs employ a multi-subunit replication/transcription machinery. A set of non-structural proteins (nsp) produced as cleavage products of the ORF1a and ORF1ab viral polyproteins (5) assemble to facilitate viral replication and transcription. A key component, the RNA-dependent RNA polymerase (RdRp, also known as nsp12), catalyzes the synthesis of viral RNA and thus plays a central role in the replication and transcription cycle of COVID-19 virus, possibly with the assistance of nsp7 and nsp8 as co-factors (6). Nsp12 is therefore considered a primary target for nucleotide analog antiviral inhibitors such as remdesivir, which shows potential for the treatment of COVID-19 viral infections (7, 8). To inform drug design we have determined the structure of nsp12, in complex with its cofactors nsp7 and nsp8 by cryo-Electron Microscopy (Cryo-EM) using two different protocols, one in the absence of DTT (Dataset-1) and the other in the presence of DTT (Dataset-2).

Apr 11, 2020

29-year-old COVID-19 patient treated with Israel’s new ‘passive vaccine’

Posted by in categories: biotech/medical, health

A 29-year-old coronavirus patient has improved from serious to serious, but stable condition after receiving multiple doses of plasma from a donor who recovered from coronavirus.


A 29-year-old haredi (ultra-Orthodox) coronavirus patient who is being treated at Samson Assuta Ashdod University Hospital has improved from serious to serious but stable condition, after receiving multiple doses of plasma over the weekend from a donor who recovered from coronavirus, a spokesperson for the hospital told The Jerusalem Post.

On Friday, “with the assistance of Health Minister Ya’acov Litzman and his assistant, a suitable donor, a resident of Jerusalem, was found,” explained MDA director-general Eli Bin.

Continue reading “29-year-old COVID-19 patient treated with Israel’s new ‘passive vaccine’” »

Apr 11, 2020

Some doctors moving away from ventilators for virus patients

Posted by in categories: biotech/medical, health

Some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients. When people talk of the safety of medicines, they need to also talk of the safety of ventilators as the wrong treatment can kill a patient, and we have enough evidence that ventilators are not working.


NEW YORK (AP) — As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can.

The reason: Some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.

Continue reading “Some doctors moving away from ventilators for virus patients” »